Yang J et al
an FDA advisory committee rejected adding it to the approved compounding list in 2024, citing toxicity and an unresolved cardiac signal
A bedside-to-bench study in Taiwan ( n = 12) reported that a novel TCM formula, Taiwan Chingguan Yihau (NRICM101), could disrupt progression of SARS-CoV-2 infection through antiviral and anti-inflammatory activities, thereby provide both preventive and therapeutic benefits to combat COVID-19 758
Similar to any medication, this skin-brightening injection may have side effects alongside its benefits
Caffeine acts as a vasoconstrictor, narrowing blood vessels in the brain that dilate during a migraine
Our new findings suggest that increasing the dose can lead to even greater benefits and may be appropriate for some patients, said study leader Ildiko Lingvay, M.D., M.P.H., M.S.C.S., Professor of Internal Medicine in the Division of Endocrinology and in the Peter ODonnell Jr